Inna Y. Gong
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Management of relapsed/refractory DLBCL in the era of novel agents and new approaches.
Journal: Leukemia & lymphoma
Published: January 05, 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.
Journal: Hematological oncology
Published: November 03, 2025
Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.
Journal: Leukemia & lymphoma
Published: November 03, 2025
Primary refractory disease in large B-cell lymphoma: definition and outcomes from a secondary analysis of the LY.12 clinical trial.
Journal: Blood advances
Published: September 24, 2025
Primary refractory disease in large B cell lymphoma: definition and outcomes from a secondary analysis of the LY.12 clinical trial.
Journal: Blood advances
Published: September 24, 2025
Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis.
Journal: Cancer
Published: August 29, 2025
Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma.
Journal: JCO precision oncology
Published: July 09, 2025
Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 02, 2024
Last Updated: 09/26/2026